TC Biopharm (Holdings) Plc (TCBP)
NASDAQ: TCBP · Real-Time Price · USD
0.371
+0.050 (15.72%)
At close: Jan 31, 2025, 4:00 PM
0.357
-0.014 (-3.80%)
After-hours: Jan 31, 2025, 7:34 PM EST
TC Biopharm (Holdings) Revenue
Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
41
Market Cap
3.05M USD
Revenue Chart
* This company reports financials in GBP.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | - | - | - |
Dec 31, 2022 | 3.84M | 1.87M | 94.30% |
Dec 31, 2021 | 1.98M | - | - |
Dec 31, 2020 | 1.98M | -1.45M | -42.26% |
Dec 31, 2019 | 3.43M | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 400.28B |
Johnson & Johnson | 88.82B |
Merck & Co. | 63.17B |
AbbVie | 56.33B |
Novartis AG | 51.72B |
AstraZeneca | 51.21B |
Thermo Fisher Scientific | 42.88B |
Abbott Laboratories | 41.95B |
TCBP News
- 17 days ago - TCBP Announces H5N1 Proof of Concept Studies Intention - PRNewsWire
- 19 days ago - TCBP to Present at Sequire Investor Summit 2025 - PRNewsWire
- 25 days ago - TCBP Trading Continues Unabated on Nasdaq Stock Exchange - PRNewsWire
- 4 weeks ago - TCBP Provides Update on Acquisition Strategy and Current Targets - PRNewsWire
- 4 weeks ago - TCBP Issues 25% Stock Dividend - PRNewsWire
- 6 weeks ago - TCBP Advances ACHIEVE Phase 2b Clinical Trial with Final Dosing of 3 Patients - PRNewsWire
- 6 weeks ago - TCBP Announces General Meeting of Shareholders to Approve One-Time Shareholder Dividend - PRNewsWire
- 6 weeks ago - EXCLUSIVE: Penny Stock TC BioPharm Proposes Special Stock Dividend - Benzinga